Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 Jun 9;334(7605):1207.
doi: 10.1136/bmj.39022.436389.BE. Epub 2006 Dec 4.

Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial

Selina H Banu  1 , Moshrat Jahan, Umme Kulsum Koli, Saadia Ferdousi, Naila Z Khan, Brian Neville
Affiliations
Randomized Controlled Trial

Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial

Selina H Banu et al. BMJ. .

Abstract

Objective: To compare the behavioural side effects associated with two commonly used antiepilepsy drugs-phenobarbital and carbamazepine-in children in Bangladesh.

Design: Prospective randomised controlled single centre trial.

Setting: Specialist children's hospital in Dhaka, Bangladesh.

Participants: 108 children aged 2-15 with generalised tonic-clonic (n=51) or partial and secondary generalised seizures (n=57).

Main outcome measures: Seizure control and behavioural side effects.

Results: 91 children were followed up for 12 months. Six required a change of antiepilepsy drug. Side effects were compared in 85 children. In the last quarter of the 12 month follow-up, 71 children were seizure free after one year's treatment. Thirty two in the phenobarbital group and 39 in the carbamazepine group had no seizures in 74 and 102 days after randomisation, respectively. Ten children had increased behavioural problems, which were unacceptable in four (one in the phenobarbital group and three in the carbamazepine group). Independent t tests, however, showed no difference between the two trial drugs.

Conclusion: There was no excess in behavioural side effects with phenobarbital in children with epilepsy in a country with limited resources. Trial registration NCT00381537.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

None
Flow of children through the trial
See this image and copyright information in PMC

Comment in

References

    1. Shorvon SD, Farmer PJ. Epilepsy in developing countries: a review of epidemiological, sociocultural and treatment aspects. Epilepsia 1988;29(suppl 1):S36-54. - PubMed
    1. WHO. Initiative of support to people with epilepsy Geneva: WHO, 1990. (WHO/MHH, MND/90.3).
    1. Gastaut H, Osontokun BO. Proposals on antiepileptic pharmacotherapy for use in developing countries. Epilepsia 1976;17:355-60. - PubMed
    1. Banu SH, Khan NZ, Hossain M, Jahan A, Parveen M, Rahman N, et al. Profile of childhood epilepsy in Bangladesh. Dev Med Child Neurol 2003;45:477-82. - PubMed
    1. de Silva M, MacArdle B, McGowan M, Hughes E, Stewart J, Neville BG, et al. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine or sodium valproate for newly diagnosed childhood epilepsy. Lancet 1996;347:709-13. - PubMed

Publication types

Associated data